ArticleHealth science reports2025
The Clinical Evaluation of Serum WS Biotin, a Novel Encapsulated Form of D-Biotin With Improved Water Solubility, for Anti-Hair Shedding Applications. A Prospective Single-Arm, Nonrandomized, Pretest-Posttest Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeted Follicular Delivery via Liposomal Encapsulation ofClinical, cosmetic and investigational dermatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Hair shedding is an aesthetic concern increasingly being addressed by the cosmetic industry. Biotin has long been used as an oral supplement to promote hair growth and strength, without solid evidence supporting this practice. Recently, we have shown that encapsulated biotin has promising bioactivity in hair growth-related parameters in vitro. For this reason, this study aimed at evaluating the association between the application of Serum WS Biotin, a novel water-soluble form of D-Biotin, and hair shedding and strength, after topical application for 3 months. Methods: A cohort of 22 volunteers with moderate to excessive hair shedding was subjected to daily application of Serum WS Biotin for 3 months. Baseline and follow-up (Days 30, 60, and 90 after the application started) Modified Pull Test (MPT), Modified Hair Wash Test (MHWT), and phototrichogrametry measurements were conducted on the study cohort. Results: Hairs pulled through MPT were reduced by 43.0% at D30, 56.0% at D60, and 76.1% at D90. Regarding MHWT, the number of vellus hairs (< 3 cm) was significantly reduced by 90.6% at D30, 67.0% at D60, and 74.8% at D90. Concomitantly, pulled hairs > 3 cm significantly diminished by 69.4% at D60 and 60.0% at D90. Contrarily, a significant increase of 227.5% was recorded at D30. Last, the hair thickness median rose significantly by 7.5% at D30, 10.6% at D60, and 7.6% at D90. Consistently, hair thickness mean was nonsignificantly increased by 4.6% at D30, 18.0% at D60, and 17.8% at D90. Interestingly, results also provided a nonstatistically significant improvement in hair mass by 3.2% at D30 and 10.4% at D90. Conclusion: The 3-month application of Serum WS Biotin displays anti-hair shedding and strengthening capabilities, showing good cutaneous acceptability and compatibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.